To evaluate the clinical effect of ultrasound-guided laser ablation therapy of prostate cancer.
Methods:
The data of long-term follow-up of one case of prostate cancer who underwent ultrasound-guided transperineal laser ablation were retrospectively analyzed and the related literatures were reviewed.
Results:
No serious side effects occurred during and after the surgery. During the two-year follow-up
prostate-specific antigen (PSA) level gradually reduced to and maintained at a relatively low level
and the imaging results showed no sign of recurrence.
Conclusion:
Ultrasound-guided laser ablation therapy of prostate cancer is a promising treatment strategy
but large sample
multi-center and prospective studies are still needed to evaluate its safety and efficacy.